Prevalence of hepatitis B and C virus markers in patients with hepatocellular carcinoma and cirrhosis

L. Stanciu, A. Par, D. Dumitrascu, D. Dejica, S. Erdossy, P. Szanto, O. Chira, O. Pascu

Research output: Contribution to journalArticle

Abstract

Eighty patients, 20 with hepatocellular carcinoma and 60 with cirrhosis, were evaluated for the presence of anti-hepatitis C virus antibodies and hepatitis B virus markers (hepatitis B surface antigen, antibodies to core and surface hepatitis B virus) by ELISA-Abbott standard kits. Seventeen (85%) patients with hepatocellular carcinoma had ulderlying cirrhosis. Serologic evidence of hepatitis C virus infection was found in 26(43.3%) patients with cirrhosis and in nine (45%) patients with hepatocellular carcinoma. The aforementioned hepatitis B virus markers were found in 47 (78.3%) patients with hepatocellular carcinoma and 5(8.3%) with cirrhosis and concurrent B and C infection. Chronic hepatitis B and C virus infection is a common etiology among patients with cirrhosis and hepatocellular carcinoma in Romania.

Original languageEnglish
Pages (from-to)235-237
Number of pages3
JournalRomanian Journal of Gastroenterology
Volume5
Issue number4
Publication statusPublished - Jan 1 1996

Keywords

  • Anti-HCV
  • Cirrhosis
  • HBV markers
  • HCC

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Prevalence of hepatitis B and C virus markers in patients with hepatocellular carcinoma and cirrhosis'. Together they form a unique fingerprint.

  • Cite this

    Stanciu, L., Par, A., Dumitrascu, D., Dejica, D., Erdossy, S., Szanto, P., Chira, O., & Pascu, O. (1996). Prevalence of hepatitis B and C virus markers in patients with hepatocellular carcinoma and cirrhosis. Romanian Journal of Gastroenterology, 5(4), 235-237.